ABA
GILD icon

American Beacon Advisors’s Gilead Sciences GILD Stock Holding History

American Beacon Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,346
Closed -$336K – 48
2018
Q3 		$336K Buy
4,346
+894
+26% +$67.5K 2.28% 10
2018
Q2 		$245K Buy
3,452
+781
+29% +$55.2K 2.25% 8
2018
Q1 		$201K Hold
2,671
– – 2.13% 9
2017
Q4 		$191K Buy
2,671
+1,378
+107% +$105K 2.04% 10
2017
Q3 		$105K Hold
1,293
– – 1.25% 34
2017
Q2 		$92K Sell
1,293
-810
-39% -$53.9K 1.17% 43
2017
Q1 		$143K Buy
+2,103
New +$148K 1.87% 7

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

American Beacon Advisors's GILD Position: Q4 2018 in Review

American Beacon Advisors sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 4,346 shares — an estimated $336K sold.

American Beacon Advisors first reported a position in GILD in Q1 2017 and held it in 7 quarters. The position peaked at $336K in Q3 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • American Beacon Advisors reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • American Beacon Advisors sold 4,346 Gilead Sciences shares in Q4 2018, an estimated $336K.
  • American Beacon Advisors first reported a position in Gilead Sciences in Q1 2017 and held it in 7 quarters.
  • American Beacon Advisors's Gilead Sciences position peaked at $336K in Q3 2018.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.